The Efficacy and Safety of Diyushengbai Tablet on Preventing and Treating Leukopenia Caused by Radiotherapy and Chemotherapy Against Tumor: A Systematic Review and Meta-Analysis

Background: Leukopenia is one of the side effects of radiotherapy and chemotherapy. Diyushengbai tablet (DYT) is used to prevent and treat leukopenia caused by various reasons. A meta-analysis was performed to systematically analyze the therapeutic effects of DYT on preventing and treating leukopenia caused by radiotherapy and chemotherapy.Objectives: This study aimed to systematically evaluate the efficacy and safety of DYT in preventing and treating leukopenia caused by radiotherapy and chemotherapy.Methods: We performed a comprehensive literature search of electronic databases such as PubMed, The Cochrane Library, China Knowledge Network (CNKI), China Biomedical Literature Database (CBM), Wanfang Data Knowledge Service Platform, and VIP, through November of 2021. The scanning reports deadline is until November 2021. The bias risk evaluation criteria developed by the Cochrane collaborative organization were used to evaluate the literature quality of the included studies. The RevMan5.4 software was used to analyze the data, and the Stata16.0 was used to perform the Egger test.Results: After selecting all the databases, a total of 41 reports which involved 3,793 cases were analyzed. Meta-analysis showed that DYT could significantly reduce the white blood cell (WBC) suppression caused by radiotherapy and chemotherapy and improve the patients’ WBC counts and neutrophils, compared with the efficacy of other oral WBC-elevating drugs such as Leucogen tablets and Batilol tablets and additional utilization of granulocyte colony-stimulating factor (G-CSF). The results of meta-analysis showed that for preventive medication purpose, the overall incidence of leukocyte suppression was [RR = 0.74, 95%CI (0.59, 0.92), p = 0.006], and the white blood cell count was [MD = 1.12, 95%CI (0.95, 1.29), p < 0.00001]; while for therapeutic purpose, the incidence of overall leukocyte suppression was [RR = 0.61, 95%CI (0.38, 0.95), p = 0.03], and the white blood cell count was [MD = 1.20, 95%CI (0.77, 1.62), p < 0.00001]. More importantly, the additional use of DYT can reduce the application amount of G-CSF. The results showed that the application of G-CSF can be reduced by an average of 1.57 from the beginning of treatment to return normal white blood cells around 2.23 in two cycles of chemotherapy.Conclusion: DYT is more effective in preventing and treating leukopenia caused by radiotherapy and chemotherapy than other oral WBC-elevating drugs, which have a high clinical value

Evolution of a Superhydrophobic H59 Brass Surface by Using Laser Texturing via Post Thermal Annealing

To fabricate an industrial and highly efficient super-hydrophobic brass surface, annealed H59 brass samples have here been textured by using a 1064 nm wavelength nanosecond fiber laser. The effects of different laser parameters (such as laser fluence, scanning speed, and repetition frequency), on the translation to super-hydrophobic surfaces, have been of special interest to study. As a result of these studies, hydrophobic properties, with larger water contact angles (WCA), were observed to appear faster than for samples that had not been heat-treated (after an evolution time of 4 days). This wettability transition, as well as the evolution of surface texture and nanograins, were caused by thermal annealing treatments, in combination with laser texturing. At first, the H59 brass samples were annealed in a Muffle furnace at temperatures of 350 °C, 600 °C, and 800 °C. As a result of these treatments, there were rapid formations of coarse surface morphologies, containing particles of both micro/nano-level dimensions, as well as enlarged distances between the laser-induced grooves. A large number of nanograins were formed on the brass metal surfaces, onto which an increased number of exceedingly small nanoparticles were attached. This combination of fine nanoparticles, with a scattered distribution of nanograins, created a hierarchic Lotus leaf-like morphology containing both micro-and nanostructured material (i.e., micro/nanostructured material). Furthermore, the distances between the nano-clusters and the size of nano-grains were observed, analyzed, and strongly coupled to the wettability transition time. Hence, the formation and evolution of functional groups on the brass surfaces were influenced by the micro/nanostructure formations on the surfaces. As a direct consequence, the surface energies became reduced, which affected the speed of the wettability transition—which became enhanced. The micro/nanostructures on the H59 brass surfaces were analyzed by using Field Emission Scanning Electron Microscopy (FESEM). The chemical compositions of these surfaces were characterized by using an Energy Dispersive Analysis System (EDS). In addition to the wettability, the surface energy was thereby analyzed with respect to the different surface micro/nanostructures as well as to the roughness characteristics. This study has provided a facile method (with an experimental proof thereof) by which it is possible to construct textured H59 brass surfaces with tunable wetting behaviors. It is also expected that these results will effectively extend the industrial applications of brass material

Nucleic Acids Enabled‐Interfacial Engineering for Biomarker Sensing with Distance Constraint Effects

Abstract Controlling the distance of molecular recognition and signal transduction at the nano–bio interface plays a vital role in sensing molecular interactions, which significantly impacts how a biomarker sensor performs in terms of sensitivity, specificity, detection threshold, and response time. However, conventional biosensing interfaces without the design of distance constraint show limited molecular interactions, hindering target accessibility and mass transport. Nuclei acid‐enabled engineering of biosensing interfaces facilitates highly regulated orientation and programmable density control of biomolecules, providing an effective strategy to improve the performance of biosensing platforms for early diagnosis of diseases and regulation of cellular activities. This review summarizes the recent advances in nucleic acid‐based engineering of biosensing interfaces from a unique perspective of distance constraint effects. The roles of structural nucleic acids in delicately programmed assemblies, functional nucleic acids in molecular recognition, and sensor reactions at well‐controlled distances are highlighted. Then applications of advanced biosensing platforms with the effect of distance constraint are introduced. Finally, the current challenges and future directions for developing such biosensors that can compete effectively to meet the requirements of point‐of‐care testing are also discussed